Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease
Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease
Recruiting · NCT07085039 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease | Castleman disease, Hemic and Lymphatic Diseases, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome | Recruiting | Phase 2 | 2026-04-22 | NCT07085039 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Incyte Corporation | 153 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| University of Pennsylvania | 502 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Pennsylvania | Philadelphia | United States | 507 |